Reclaim Your Rise: Type 1 Diabetes with Lauren Bongiorno
Lauren Bongiorno is a Nationally Board Certified Health Coach and the founder and CEO of Risely Health. Featured on the TODAY show and other media outlets, Risely helps people and families impacted by Type 1 Diabetes take ownership over their health so they can transform their life with more freedom and confidence. Lauren has lived with type 1 diabetes since she was 7 years old and has experienced firsthand that when health transforms, so does everything else - our relationships, our time, our career, our families, and, most importantly, ourselves. Each week she will bring you lessons from her own personal diabetes experience, strategies that are key to understanding your body’s patterns, and guests who will speak to everything from advances in technology to all things hormones, exercise, relationships, and mindset. All of this so that over time, you TOO can reclaim your rise.
Reclaim Your Rise: Type 1 Diabetes with Lauren Bongiorno
245. A Future Without Insulin? New Research for People Newly Diagnosed With Type 1 Diabetes (ft. Sam Reich)
Use Left/Right to seek, Home/End to jump to start or end. Hold shift to jump forward or backward.
What if the way we treat type 1 diabetes right after diagnosis could help someone keep producing their own insulin for longer?
In this episode, Lauren sits down with Samuel Reich, CEO of SAB Bio, to talk about SAB-142, an investigational therapy being studied to protect the insulin-producing cells someone still has when they’re diagnosed with T1D.
Sam breaks down why researchers are racing to protect the insulin your body still makes at diagnosis, what they’re studying both within the first 100 days and as far as two years after diagnosis, and how preserving that insulin could change life with T1D. He also shares his vision for a future where T1D is caught early enough that some people may never need insulin at all.
SAB-142 is still being studied, but this conversation offers an exciting look at how different a T1D diagnosis could become in the years ahead.
WHAT WE COVER:
- How to find out if your child may be eligible for the SAFEGUARD Study and what steps to take if they are
- Why you may still have functioning insulin-producing cells when you’re diagnosed with T1D and what could happen if we protect them
- Whether preserving your remaining beta cells could mean less insulin, a lower A1C, and more time in range
- What researchers saw in C-peptide levels just four months into the first SAB-142 study
- Why researchers are questioning whether time since diagnosis matters as much as how much insulin your body can still produce
- Why people up to two years past diagnosis are now being studied, even though most newly diagnosed T1D trials focus on a much shorter window
- How catching T1D before insulin is needed could completely change what a diagnosis looks like 10 to 15 years from now
WHAT’S NEXT:
👉If your child was recently diagnosed with type 1 diabetes, go to SafeGuardStudy.com to learn more about the SAFEGUARD study and see if they may qualify.
🏋️ Want to make exercise with T1D more predictable? Join our 8-week Exercise & Insulin Sensitivity Coaching Program to learn how to stay in range during movement, improve insulin sensitivity, and build strategies that work for YOUR body. Our next group starts October 20th and spots are limited.
💻Apply for coaching and talk to our team so you can reclaim the life you deserve with T1D.
📧Join thousands of T1Ds reading our newsletter every Tuesday: T1D tips and encouragement, straight to your inbox.
Stay connected with us:
Email us at: hello@riseyhealth.com
IG: @lauren_bongiorno | @riselyhealth
TikTok: @lauren_bongiorno | @riselyhealth
YT: Reclaim Your Rise
SUBSCRIBE & REVIEW
The more T1D research evolves, the more important it is that our community knows what’s possible. Subscribe and leave a review to help more people with T1D find conversations like this one.
